CLARK IAN T sold $2.3M of GH (indirect holdings)
CLARK IAN T sold 14,180 indirectly-held shares of Guardant Health, Inc. (GH) at an average of $158.92 ($158.80–$158.98, $2.25M total) across 2 trades on 2026-08-04.
How this was made
The 30-second read
Why it matters
The newest fact is the director’s open-market sale of 14,180 shares (about $2.25M) at roughly $158.8 to $159.0 per share, with holdings after the sale of 2,975 shares.
Market read
Traders may note the insider sale as a sentiment datapoint, but it does not introduce new company fundamentals or guidance.
What to watch
No 10b5-1 plan is disclosed here, but the article also provides no context on total holdings, prior sale cadence, or whether other insiders are buying or selling around the same period.
Background
This is an SEC Form 4 insider transaction disclosure for Guardant Health, Inc., reported by a director.
Ticker impact
Guardant Health director Clark Ian T sold $2.25M of GH shares via two open-market trades at about $158.9 on 2026-08-04.
Limited near-term impact; any effect is likely transient unless followed by additional insider selling or new company-specific catalysts.
The filing is a Form 4 insider transaction with no 10b5-1 plan and a moderate dollar value, but it does not include new operational, financial, or regulatory information.
Market effects
Minimal; insider selling at one healthcare diagnostics name does not materially change sector expectations.
None indicated.
None indicated.
Counterpoint
The sale may be driven by personal liquidity needs rather than a view on business prospects, especially given the lack of a stated fundamental catalyst in the filing.
Key entities
- issuerGuardant Health, Inc.
Company whose shares were sold by an insider director via open-market transactions.
- insiderCLARK IAN T
Director who sold 14,180 shares of GH on 2026-08-04, reported on 2026-08-05.
